Compare Equity Development Investment Tbk. (GSMF) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equity Development Investment Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Equity Development Investment Tbk. trades at Rp106 (market cap 1.92T, 294.19M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Equity Development Investment Tbk. is far larger — about 18.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| GSMF | SCPI | |
|---|---|---|
Market Cap | 1.92T | 104.4B |
Volume | 294.19M | — |
Lot | 2.94M | — |
Turnover | 36.95B | — |
Average Price | 125.58 | — |
Value | 36.95B | — |
Indicative Equilibrium Price | 106 | — |
Indicative Equilibrium Volume | 8.47K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equity Development Investment Tbk.
PT Equity Development Investment Tbk (the “Company”) was established in Jakarta under the name of PT Gajah Surya Arta Leasing on November 1, 1982 based on the Notarial Deed of Didi Sudjadi, S.H., No. 1, as amended by deed No. 30 dated March 6, 1985 of the same notary. The Company changed its name to be PT BDNI Capital Corporation Tbk. On February 7, 2001, it changed the named again to be PT GT Investama Kapital, Tbk.
Read more on GSMF →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
